First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

Marscha Holleman, H van Tinteren, HJM Groen, Maiwenn Al, Carin Uyl - de Groot

Research output: Contribution to journalArticleAcademicpeer-review

11 Downloads (Pure)
Original languageEnglish
Pages (from-to)1413-1421
Number of pages9
JournalOncoTargets and Therapy
Volume12
DOIs
Publication statusPublished - 2019

Cite this